4//SEC Filing
Reikes Peter N 4
Accession 0000874015-20-000094
CIK 0000874015other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:28 PM ET
Size
12.7 KB
Accession
0000874015-20-000094
Insider Transaction Report
Form 4
Reikes Peter N
Director
Transactions
- Exercise/Conversion
Common Stock
2020-07-01+1,778→ 3,556 total - Exercise/Conversion
Restricted Stock Units
2020-07-01−1,778→ 5,332 total→ Common Stock (1,778 underlying) - Award
Restricted Stock Units
2020-07-01+5,333→ 5,333 totalExercise: $0.00→ Common Stock (5,333 underlying) - Award
Director Stock Option (right to buy)
2020-07-01+12,000→ 12,000 totalExercise: $60.20From: 2021-07-01Exp: 2030-06-30→ Common Stock (12,000 underlying)
Footnotes (5)
- [F1]Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F3]These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
- [F4]Grant of July 1, 2020 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2020.
- [F5]Grant of July 1, 2020 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2020.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001753652
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:28 PM ET
- Size
- 12.7 KB